CAS 2241659-94-7

1,4-Cyclohexanediamine, N1-[5-methyl-4-(6-phenylimidazo[1,2-a]pyridin-3-yl)-2-pyrimidinyl]-, trans-

Description:

1,4-Cyclohexanediamine, N1-[5-methyl-4-(6-phenylimidazo[1,2-a]pyridin-3-yl)-2-pyrimidinyl]-, trans- is a complex organic compound characterized by its bicyclic structure, which includes a cyclohexane ring and multiple heterocyclic components. The presence of both imidazo and pyrimidine rings suggests potential biological activity, as these structures are often found in pharmaceuticals and bioactive molecules. The trans configuration indicates specific spatial arrangements of substituents around the cyclohexane ring, which can influence the compound's reactivity and interaction with biological targets. This compound may exhibit properties such as solubility in organic solvents, moderate stability under standard conditions, and potential for forming hydrogen bonds due to the presence of amino groups. Its unique structure may also contribute to specific pharmacological effects, making it of interest in medicinal chemistry. However, detailed studies would be necessary to fully understand its properties, including its synthesis, reactivity, and potential applications in drug development or other fields.

Formula: C₂₄H₂₆N₆

Synonyms:

• 1,4-Cyclohexanediamine, N1-[5-methyl-4-(6-phenylimidazo[1,2-a]pyridin-3-yl)-2-pyrimidinyl]-, trans-
• CDDD11-8

CDDD11-8

CAS: 2241659-94-7

CDDD11-8 is an orally administered, highly potent and selective CDK9 and FLT3-ITD inhibitor, with K i values of 8 nM and 13 nM, respectively. It effectively reduces the proliferation of leukemia cell lines, showing particular efficacy against those with the FLT3-ITD mutation [1] [2].

Formula: C₂₄H₂₆N₆

Color and Shape: Solid

Molecular weight: 398.50

Ref: TM-T86025